Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Pharm Sci ; 108(6): 2012-2021, 2019 06.
Artículo en Inglés | MEDLINE | ID: mdl-30639741

RESUMEN

Polygeline is a highly promising drug carrier-oriented material for important applications in pharmacy field due to its low-cost and unique properties similar to albumin. In this study, polygeline-bound paclitaxel nanoparticles (Npb-PTXS) were fabricated through a combination of low-pressure emulsification and high-pressure homogenization. The effects of a series of production parameters on mean particle size, particle size distribution and drug loading of Npb-PTXS were systematically evaluated. The characteristics of Npb-PTXS, such as surface morphology, physical status of paclitaxel (PTX) in Npb-PTXS, redispersibility of Npb-PTXS in purified water and bioavailability in vivo were also investigated. It is revealed that the optimal preparation conditions included an aqueous phase pH value of about 6.5, protein mass concentration of 0.33%, with mass ratio of PTX to protein of 30%, high pressure of 1200 bar, high-pressure passes of 25 times and low-pressure emulsifying passes of 20 times. Obtained Npb-PTXS shows good resolubility compared to commercially available Abraxane®, containing round or oval shaped particles with mean particle size of around 188.3 nm, polydispersity index of 0.163 and zeta potential of -31.1 mV. PTX in Npb-PTX is amorphous, and its content is approximately 12.04%. Encapsulation efficiency of Npb-PTXS reaches 81.2%. Moreover, in vivo pharmacokinetic studies showed that the intravenous relative bioavailability of Npb-PTXS to Abraxane was 83.89%.


Asunto(s)
Antineoplásicos Fitogénicos/administración & dosificación , Portadores de Fármacos/química , Composición de Medicamentos/métodos , Paclitaxel/administración & dosificación , Poligelina/química , Administración Intravenosa , Paclitaxel Unido a Albúmina/administración & dosificación , Paclitaxel Unido a Albúmina/farmacocinética , Animales , Antineoplásicos Fitogénicos/farmacocinética , Disponibilidad Biológica , Emulsiones , Masculino , Modelos Animales , Nanopartículas/química , Paclitaxel/farmacocinética , Tamaño de la Partícula , Ratas , Solubilidad , Organismos Libres de Patógenos Específicos
2.
Sheng Wu Gong Cheng Xue Bao ; 27(2): 164-71, 2011 Feb.
Artículo en Chino | MEDLINE | ID: mdl-21650040

RESUMEN

Global warming caused by the increasing CO2 concentration in atmosphere is a serious problem in the international political, economic, scientific and environmental fields in recent years. Intensive carbon dioxide capture and storage (CCS) technologies have been developed for a feasible system to remove CO2 from industrial exhaust gases especially for combustion flue gas. In these technologies, the biofixation of CO2 by microalgae has the potential to diminish CO2 and produce the biomass. In this review, the current status focusing on biofixation of CO2 from combustion flue gases by microalgae including the selection of microalgal species and effect of flue gas conditions, the development of high efficient photobioreactor and the application of microalgae and its biomass product were reviewed and summarized. Finally, the perspectives of the technology were also discussed.


Asunto(s)
Contaminantes Atmosféricos/aislamiento & purificación , Contaminación del Aire/prevención & control , Dióxido de Carbono/aislamiento & purificación , Microalgas/metabolismo , Contaminantes Atmosféricos/metabolismo , Biodegradación Ambiental , Dióxido de Carbono/metabolismo , Fotoquímica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA